REGULATED PRESS RELEASE
News
-
-
PRESS RELEASE
Baloise achieves a very healthy profit for the period and makes significant progress with implementing its refocusing strategy
Baloise achieves a very healthy profit for the period and shows significant progress with its refocusing strategy implementation, reporting promising half-year financial results -
PRESS RELEASE
Bioversys reports corporate highlights and key financials for the first half 2025
BioVersys AG reports key financials and corporate highlights for the first half of 2025, including successful Phase 2 outcomes: BV100 Phase 3 on track, Alpibectir Phase 2 with GSK, BV500 collaboration with Shionogi, improved FY 2025 guidance -
REGULATED PRESS RELEASE
Museum Studio enters exclusive discussions to acquire, operate and develop Chaplin’s World internationally
Museum Studio in exclusive talks to acquire and expand Chaplin's World internationally, celebrating the cinematic universe of Charlie Chaplin. Acquisition to enhance cultural offerings globally -
REGULATED PRESS RELEASE
TINC publishes strong interim results and is well on track to double its investment portfolio with the proceeds of the recent rights issue fully invested
TINC reports strong interim results, fully investing recent rights issue proceeds to double investment portfolio. Shareholders' equity grows to €615.3 million -
-
-
-
-
PRESS RELEASE
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development
